ORYGEN Youth Health and Department of Psychiatry, University of Melbourne, Parkville, Victoria
ORYGEN Research Centre and Department of Psychiatry, University of Melbourne, Parkville, Victoria
ORYGEN Youth Health and Department of Psychiatry, University of Melbourne, Parkville, Victoria
School of Population Health, University of Queensland, Queensland Centre for Mental Health Research, Richlands, Queensland
Department of Medicine, University of Melbourne at St Vincent's Hospital, Fitzroy, Victoria
ORYGEN Youth Health, ORYGEN Research Centre and Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia
Correspondence: Darryl Wade, ORYGEN Youth Health, Locked Bag 10, Parkville 3052, Australia. Email: dwade{at}unimelb.edu.au
* The results of this paper were presented in part at the 4th International Early Psychosis Conference, Vancouver, Canada, 28 September to 1 October, 2004.
Background Well-designed prospective studies of substance misuse in first-episode psychosis can improve our understanding of the risks associated with comorbid substance misuse and psychosis.
Aims To examine the potential effects of substance misuse on in-patient admission and remission and relapse of positive symptoms in first-episode psychosis.
Method The study was a prospective 15-month follow-up investigation of 103 patients with first-episode psychosis recruited from three mental health services.
Results Substance misuse was independently associated with increased risk of in-patient admission, relapse of positive symptoms and shorter time to relapse of positive symptoms after controlling for potential confounding factors. Substance misuse was not associated with remission or time to remission of positive symptoms. Heavy substance misuse was associated with increased riskof in-patient admission, relapse and shorter time to relapse.
Conclusions Substance misuse is an independent risk factor for a problematic recovery from first-episode psychosis.
Related articles in BJP:
This article has been cited by other articles:
![]() |
A. Turkington, C. C. Mulholland, T. M. Rushe, R. Anderson, R. McCaul, S. L. Barrett, R. S. Barr, and S. J. Cooper Impact of persistent substance misuse on 1-year outcome in first-episode psychosis The British Journal of Psychiatry, September 1, 2009; 195(3): 242 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zammit, T. H. M. Moore, A. Lingford-Hughes, T. R. E. Barnes, P. B. Jones, M. Burke, and G. Lewis Effects of cannabis use on outcomes of psychotic disorders: systematic review The British Journal of Psychiatry, November 1, 2008; 193(5): 357 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M.A. Sinclair, A. H. Latifi, and A. W. Latifi Co-morbid substance misuse in psychiatric patients: prevalence and association with length of inpatient stay J Psychopharmacol, January 1, 2008; 22(1): 92 - 99. [Abstract] [PDF] |
||||
![]() |
S. Archie, B. R. Rush, N. Akhtar-Danesh, R. Norman, A. Malla, P. Roy, and R. B. Zipursky Substance Use and Abuse in First-Episode Psychosis: Prevalence Before and After Early Intervention Schizophr Bull, November 1, 2007; 33(6): 1354 - 1363. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Malla Remission one year after emergency admission is higher for substance-induced psychosis than primary psychosis Evid. Based Ment. Health, May 1, 2007; 10(2): 41 - 41. [Full Text] [PDF] |
||||